129 MN Clinics Received Drugs from Mass. Pharmacy
The Minnesota Department of Health says 129 clinics in Minnesota received injectable drugs from a pharmacy linked to a meningitis outbreak.
The health department is contacting those clinics to make sure they are contacting their patients who were given the drugs.
On Monday, U.S. health officials said two more drugs from the New England Compounding Center of Framingham, Mass., are now being investigated.
Previously, health officials were focusing on contacting and evaluating those patients who received injections of a steroid suspected of being contaminated. In Minnesota, that amounted to about 985 patients who received spinal injections at Twin Cities pain clinics. Almost all of those patients have been contacted.
The number of confirmed fungal meningitis cases in Minnesota linked to tainted steroids remains at five.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
- Mass. Firm in Meningitis Case Eyes Bankruptcy Help
- Minn. Records 13th Illness from Tainted Steroids
- Senate Health Chair Wants New Drug Compound Rules
- Owner of Meningitis-Linked Pharmacy Takes Fifth
- Ham Lake Woman Sues After Contracting Meningitis
- Lawmakers Issue Subpoena for Pharmacy Director
- FDA Chief Will Testify at First Meningitis Hearing
- Tests Find Bacteria in Products of Mass. Pharmacy
- Meningitis Outbreak Toll: 377 Illnesses, 29 Deaths
- Mass. Firm Tied to Closed Pharmacy Issues Recall